Short Interest in iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Rises By 133.6%

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 3,170 shares, a growth of 133.6% from the December 31st total of 1,357 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 18,112 shares, the short-interest ratio is currently 0.2 days. Based on an average daily trading volume, of 18,112 shares, the short-interest ratio is currently 0.2 days. Currently, 0.2% of the company’s stock are sold short.

iShares LifePath Target Date 2045 ETF Price Performance

Shares of iShares LifePath Target Date 2045 ETF stock traded down $0.28 on Friday, hitting $37.20. The company had a trading volume of 20,729 shares, compared to its average volume of 17,001. The stock has a 50-day moving average of $36.73 and a 200-day moving average of $35.83. iShares LifePath Target Date 2045 ETF has a twelve month low of $27.42 and a twelve month high of $37.64. The firm has a market capitalization of $58.03 million, a P/E ratio of 20.03 and a beta of 0.82.

Hedge Funds Weigh In On iShares LifePath Target Date 2045 ETF

A number of large investors have recently added to or reduced their stakes in ITDE. Sunbelt Securities Inc. lifted its holdings in shares of iShares LifePath Target Date 2045 ETF by 2,054.5% in the third quarter. Sunbelt Securities Inc. now owns 2,607 shares of the company’s stock valued at $94,000 after purchasing an additional 2,486 shares in the last quarter. Susquehanna International Group LLP grew its holdings in shares of iShares LifePath Target Date 2045 ETF by 38.4% during the third quarter. Susquehanna International Group LLP now owns 9,001 shares of the company’s stock worth $323,000 after buying an additional 2,496 shares in the last quarter. Geneos Wealth Management Inc. acquired a new stake in iShares LifePath Target Date 2045 ETF in the 1st quarter valued at approximately $34,000. Finally, Capital Advisors Ltd. LLC bought a new stake in iShares LifePath Target Date 2045 ETF in the 4th quarter valued at approximately $53,000.

iShares LifePath Target Date 2045 ETF Company Profile

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.